Using mRNA Display to Find Cyclic Peptides That Can Penetrate Cell Membranes

Researchers used mRNA display — a technique that screens trillions of peptide variants simultaneously — to discover cyclic peptides capable of penetrating biological membranes. The top hit, cyclo[Glut-MRKRHASRRE-K*], successfully penetrated both fruit fly embryos and mammalian cells (human embryonic stem cells and mouse fibroblasts). This is notable because no previously known peptide could cross both cytoplasmic membranes and the tough outer embryonic membrane. The cyclic version significantly outperformed its linear (non-cyclized) counterpart.

The researchers constructed large libraries of cyclic peptides using mRNA display, a technique where each peptide is physically linked to its own genetic code, allowing rapid identification of hits. They screened these libraries against fruit fly embryos at different developmental stages to select peptides that could penetrate tough embryonic membranes. Top candidates were then tested against mammalian cells. Permeation was measured using confocal microscopy (visual confirmation) and flow cytometry (quantitative measurement of how much peptide entered cells).

One of the biggest challenges in drug delivery is getting therapeutic molecules inside cells. Cell-penetrating peptides are promising delivery vehicles, but most have limited ability to cross different types of membranes. This study introduces a high-throughput method to discover cyclic peptides with unusually broad membrane-penetrating ability — which could be used to deliver drugs, gene therapies, or research tools into cells that were previously difficult to access.

mRNA display and related techniques (like phage display) are revolutionizing how researchers discover peptides with specific functions. The ability to screen billions of candidates at once means scientists can find needles in molecular haystacks. Cyclic peptides are especially interesting because their ring structure makes them more stable and often more potent than linear peptides. This study connects two hot areas of peptide science — high-throughput discovery and cell-penetrating delivery — and could accelerate the development of peptide-based drug delivery systems.

This is an in vitro proof-of-concept study. The peptides were tested in cell lines and embryos, not in living organisms. Whether they can deliver actual drug cargo — not just themselves — across membranes hasn't been demonstrated. The fruit fly embryo screen may select for properties that don't perfectly translate to all mammalian cell types. Toxicity at therapeutic doses in vivo is unknown.